Small-Firm Strategic Research Partnerships: The Case of Biotechnology
Technology Analysis and Strategic ManagementPublished 1 June 2003
David B. Audretsch, Maryann P. Feldman
Citations140
SJR quartileQ2
SJR score0.79
SNIP1.35
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
An overview of the theoretical motivation and empirical literature on small firm strategic alliances in biotechnology, an industry where these alliances have proliferated, is provided.
Abstract
This paper provides an overview of the theoretical motivation and the empirical literature on small firm strategic alliances in biotechnology, an industry where these alliances have proliferated. We begin by examining the alliance strategy for knowledge-based small firms in general and then turn our attention to the case of biotech.
Keywords
Business, Management and Accounting
The Quarterly Journal of EconomicsThe Market for "Lemons": Quality Uncertainty and the Market Mechanism
22,642 Citations1970George A. Akerlof
American Economic ReviewCredit Rationing in Markets with Imperfect Information
12,858 Citations1981Joseph E. Stiglitz, Andrew Weiss
Journal of Political EconomyThe Costs and Benefits of Ownership: A Theory of Vertical and Lateral Integration
9,389 Citations1986Sanford J. Grossman, Oliver Hart
Administrative Science QuarterlyInterorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology
8,372 Citations1996Walter W. Powell, Kenneth W. Koput +1 more
Journal of Political EconomyMonitoring and Reputation: The Choice between Bank Loans and Directly Placed Debt
3,351 Citations1991Douglas W. Diamond
Strategic Management JournalJoint ventures: Theoretical and empirical perspectives
3,338 Citations1988Bruce Kogut
RePEc: Research Papers in EconomicsFirms, Contracts, and Financial Structure
2,912 Citations1995Oliver Hart
Administrative Science QuarterlyInterorganizational Endorsements and the Performance of Entrepreneurial Ventures
2,775 Citations1999Toby E. Stuart, Ha Hoang +1 more
Strategic Management JournalUnderstanding the rationale of strategic technology partnering: Interorganizational modes of cooperation and sectoral differences
2,244 Citations1993John Hagedoorn
Intellectual Human Capital and the Birth of US Biotechnology Enterprises
1,678 Citations2003Lynne G. Zucker, Michael R. Darby +1 more
The Quarterly Journal of EconomicsImperfect Information, Uncertainty, and Credit Rationing
1,418 Citations1976Dwight M. Jaffee, Thomas Russell
Journal of Industrial EconomicsAbsorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery
1,220 Citations1998Iain Cockburn, Rebecca Henderson
The authors examine the interface between for-profit and publicly funded pharmaceuticals, finding that 'Connectedness' is significantly correlated with firms' internal organization, as well as their performance in drug discovery.
Journal of Industrial EconomicsThe Control of Technology Alliances: An Empirical Analysis of the Biotechnology Industry
658 Citations1998Josh Lerner, Robert P. Merges
Research PolicyAn analysis of the critical role of public science in innovation: the case of biotechnology
478 Citations2000G. Steven McMillan, Francis Narin +1 more
It is concluded that as biotechnology continues to develop and revolutionize many fields of industry, continued public support of basic research will give the U.S. a strategic advantage economically.
The Development Factory: Unlocking the Potential of Process Innovation
357 Citations1996Gary P. Pisano
Sources of economic growth
354 Citations2013
The Review of Economics and StatisticsStrategic Groups and the Structure-Performance Relationship
268 Citations1978Howard H. Newman
Journal of Industrial EconomicsMarket Structure, Oligopoly, and Stability of Market Shares
234 Citations1978Richard E. Caves, Michael E. Porter
Journal of Industrial EconomicsMeasuring R & D in Small Firms: How Much are we Missing?
231 Citations1987Alfred Kleinknecht
The Business History ReviewPharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation
206 Citations1998Louis Galambos, Jeffrey L. Sturchio
The authors examine the most recent such transition, the shift to molecular genetics and recombinant DNA technology (1970 to the present), and explain how and why this transformation differed from the previous ones in pharmaceuticals.
Edward Elgar Publishing eBooksFirm Size, University Based Research, and the Returns to R & D
183 Citations2017Albert N. Link, John Rees
Research PolicyExternal partnering as a response to innovation barriers and global competition in biotechnology
115 Citations1995Noel P. Greis, Mark D. Dibner +1 more
A framework is presented for explaining the choices biotechnology firms make in securing the complementary assets needed to commercialize their biotechnologies and whether partnering choices can be motivated and explained by factors in the global competitive environment.
Proceedings of the National Academy of SciencesThe challenge of contracting for technological information
86 Citations1996Richard Zeckhauser
New organizational forms are a promising approach to contracting difficulties for TI, involving universities, start-up firms, corporate giants, and venture capitalists play a major role in facilitating the production and spread of TI.
The American Historical ReviewNetworks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995
86 Citations1998Glenn Sonnedecker, Louis Galambos +1 more
Small Business EconomicsThe Changing Rewards to Science: The Case of Biotechnology
82 Citations1998Paula E. Stephan, Stephen S. Everhart
Examining the compensation of university-based scientists involved with 52 biotech firms that made an initial public offering between March of 1990 and November of 1992 suggests that the rewards to science can be significantly greater than previous work would suggest.
Entrepreneurship and Regional DevelopmentClosing the innovative loop: moving from the laboratory to the shop floor in biotechnology manufacturing
66 Citations2001Maryann P. Feldman, Cynthia R. Ronzio
Journal of Agricultural and Applied EconomicsVertical and Horizontal Coordination in the Agro-biotechnology Industry: Evidence and Implications
61 Citations1997Nicholas Kalaitzandonakes, Bruce Bjornson
International Journal of BiotechnologyThe science of nations: European multinationals and American biotechnology
44 Citations1999Margaret Sharp
California Management ReviewPatterns of Strategic Choice in Emerging Firms: Positioning for Innovation in Biotechnology
38 Citations1990William F. Hamilton, J. A. Romagosa Vila +1 more
This analysis of new U.S. biotechnology firms reveals four distinct positioning strategies that reflect differences in research and development priorities, emphases on external collaboration, and the timing of strategic choices.
Technology Analysis and Strategic ManagementThe degree of integration in strategic alliances in biotechnology
27 Citations1996Martha Prevezer, Saadet Toker
Journal of Industry StudiesGlobal R&D networks
17 Citations1993D. Jane Bower, Erica Whittaker
The case of Merck and its carefully constructed AIDS programme is examined, which balances in-house development with longterm alliances forged with smaller firms and sometimes with competitors.
National Bureau of Economic ResearchDo Equity Financing Cycles Matter? Evidence from Biotechnology Alliances
14 Citations2000Josh Lerner, Alexander C. Tsai
